• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

少菌型麻风病的违约者是个问题吗?

Are defaulters with paucibacillary leprosy a problem?

作者信息

Jesudasan K, Bradley D, Christian M

出版信息

Indian J Lepr. 1985 Apr-Jun;57(2):354-9.

PMID:4078362
Abstract

This study examined the risk of relapse in 421 paucibacillary patients who had defaulted after varying periods of dapsone monotherapy; short of the recommended course. The 421 patients contributed a total of 2,162 person years of risk; 10 patients relapsed, giving a relapse rate of 4.6 per 1000 persons years of risk, or a crude relapse rate (RR) of 2.4%. This paper discusses the issue of defaulters with paucibacillary leprosy and the findings of the study suggest that defaulters with paucibacillary leprosy are not a serious problem in terms of leprosy control.

摘要

本研究调查了421例少菌型患者在接受不同疗程的氨苯砜单药治疗(未达推荐疗程)后复发的风险。这421例患者共产生了2162人年的风险;其中10例复发,复发率为每1000人年风险中有4.6例,即粗复发率(RR)为2.4%。本文讨论了少菌型麻风病患者中断治疗的问题,研究结果表明,就麻风病控制而言,少菌型麻风病患者中断治疗并非严重问题。

相似文献

1
Are defaulters with paucibacillary leprosy a problem?少菌型麻风病的违约者是个问题吗?
Indian J Lepr. 1985 Apr-Jun;57(2):354-9.
2
Relapses in leprosy patients after release from dapsone monotherapy; experience in the leprosy control program of the all Africa Leprosy and Rehabilitation Training Center (ALERT) in Ethiopia.氨苯砜单药治疗停药后麻风患者的复发情况;埃塞俄比亚全非洲麻风病与康复培训中心(ALERT)麻风病防治项目的经验。
Int J Lepr Other Mycobact Dis. 1992 Jun;60(2):161-72.
3
Risk of paucibacillary leprosy patients released from control relapsing with multibacillary leprosy.从控制中释放的少菌型麻风病患者复发为多菌型麻风病的风险。
Int J Lepr Other Mycobact Dis. 1985 Mar;53(1):19-21.
4
Relapse rates among nonlepromatous patients released from control.
Int J Lepr Other Mycobact Dis. 1984 Sep;52(3):304-10.
5
Studies on risk of leprosy relapses in China: relapses after treatment with dapsone monotherapy.中国麻风病复发风险的研究:单用氨苯砜治疗后的复发情况
Int J Lepr Other Mycobact Dis. 1999 Dec;67(4):371-8.
6
Relapses in paucibacillary patients after treatment with three short-term regimens containing rifampin.
Int J Lepr Other Mycobact Dis. 1989 Jun;57(2):458-64.
7
Rate of relapse in multibacillary patients after cessation of long-course dapsone monotherapy supplemented by a final supervised single dose of 1500 mg of rifampin.
Int J Lepr Other Mycobact Dis. 1994 Jun;62(2):215-9.
8
Relapse rates in patients treated with dapsone monotherapy and combinations of dapsone and thiambutosine, thiacetazone, isoniazid and streptomycin in the pre-MDT era.
Int J Lepr Other Mycobact Dis. 1994 Sep;62(3):353-8.
9
Problems of leprosy relapse in China.
Int J Lepr Other Mycobact Dis. 1993 Mar;61(1):1-7.
10
Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy.在接受氨苯砜单药全疗程治疗后,采用改良多药联合治疗方案对MB型麻风患者进行25年随访。
Lepr Rev. 2009 Jun;80(2):170-6.